Quality & Compliance

Contamination Control Strategy

Structured contamination-control support to identify contamination risks, strengthen preventive controls, and maintain a state of control across regulated manufacturing environments.

Overview

Contamination control is critical to protecting product quality and patient safety, particularly in sterile, non-sterile, high-potency, biological, and other controlled manufacturing environments.

Mediature GxP Solutions Pvt. Ltd. (MGS) supports pharmaceutical, biopharmaceutical, API, medical-device, and other regulated organizations in developing, reviewing, and strengthening Contamination Control Strategies (CCS).

Our approach evaluates how facility design, personnel and material flow, utilities, cleaning, environmental monitoring, process controls, maintenance, qualification, and quality systems work together to prevent microbial, particulate, chemical, and cross-contamination risks.

MGS focuses on building an integrated, risk-based contamination-control framework rather than treating individual controls in isolation.

Our Contamination Control Services

CCS Development

Development of a structured Contamination Control Strategy that brings together critical contamination-control measures across the facility and process lifecycle.

CCS Gap Assessment

Assessment of existing contamination-control practices to identify missing controls, weak interfaces, and opportunities for improvement.

Facility & Flow Assessment

Evaluation of zoning, segregation, personnel flow, material movement, waste movement, pressure cascades, and contamination-transfer risks.

HVAC & Cleanroom Assessment

Review of HVAC design, filtration, airflows, pressure differentials, temperature and humidity control, cleanroom classification, and qualification status.

Cleaning & Disinfection Strategy

Assessment of cleaning procedures, disinfectant selection, rotation, contact times, cleaning validation, residue control, and routine implementation.

Environmental Monitoring Review

Evaluation of monitoring locations, frequencies, alert/action levels, trending, excursion handling, and linkage with facility and process risks.

Cross-Contamination Control

Assessment of segregation, campaign controls, cleaning validation, shared equipment, product changeover, and containment measures.

Personnel & Gowning Controls

Review of gowning practices, hygiene, personnel qualification, movement controls, behavior, and aseptic practices where applicable.

Utility & Support-System Controls

Assessment of utilities such as water, clean steam, compressed gases, and other systems that may influence contamination risk.

High-Potency & Containment Support

Evaluation of containment strategies, segregation, exposure controls, engineering measures, and cross-contamination prevention for potent products.

Key CCS Focus Areas

Depending on scope, MGS may assess:

  • Facility design and zoning
  • Personnel flow
  • Material flow
  • Waste movement
  • HVAC and pressure differentials
  • Cleanroom classification
  • Airflow patterns
  • Environmental monitoring
  • Cleaning and disinfection
  • Cleaning validation
  • Cross-contamination control
  • Equipment design
  • Shared-equipment controls
  • Utility systems
  • Water systems
  • Compressed gases
  • Personnel hygiene
  • Gowning
  • Aseptic practices
  • Material transfer
  • Maintenance activities
  • Pest control
  • Supplier-related contamination risks
  • Microbial control
  • Particulate control
  • Chemical contamination
  • High-potency containment
  • Deviation and CAPA trends
  • Change control
  • Qualification and requalification
  • Training and competency

Our Approach

  • Understand the Process

Understand the products, manufacturing processes, facility layout, contamination risks, utilities, personnel practices, and regulatory expectations.

  • Map Contamination Risks

Identify potential contamination pathways across people, materials, equipment, air, utilities, cleaning, and supporting activities.

  • Evaluate Existing Controls

Review preventive and monitoring controls to determine whether they are suitable, effective, and appropriately integrated.

  • Identify Gaps

Highlight weaknesses, missing controls, conflicting practices, and areas where contamination risk is not adequately managed.

  •  Develop the CCS

Create or strengthen the Contamination Control Strategy with clear controls, responsibilities, monitoring mechanisms, and risk rationale.

  • Implement & Review

Support rollout, training, remediation, effectiveness review, and periodic update of the CCS as systems and processes evolve.

CCS Deliverables

Depending on the agreed scope, MGS can provide:

  • CCS gap-assessment report
  • Contamination-risk map
  • Facility and flow assessment
  • HVAC and cleanroom review
  • Cleaning and disinfection assessment
  • Environmental monitoring review
  • Cross-contamination risk assessment
  • High-potency containment review
  • CCS document development
  • Remediation roadmap
  • SOP recommendations
  • Training support
  • Periodic CCS review framework

Why Choose MGS for Contamination Control Strategy

Integrated Perspective

MGS evaluates contamination control across facility, HVAC, utilities, process, cleaning, environmental monitoring, personnel, validation, and quality systems.

Risk-Based Approach

Controls are prioritized according to the potential impact on product quality, patient safety, and contamination risk.

Engineering & Quality Expertise

Our approach combines GMP, engineering, validation, microbiological, and quality-system perspectives.

Practical Implementation

Recommendations are developed with consideration of the actual facility, process, product, and operational constraints.

High-Potency & Containment Capability

MGS can support specialized contamination-control requirements for potent and containment environments.

Lifecycle Thinking

The CCS is treated as a living strategy that should evolve with facility changes, new products, deviations, trends, and regulatory expectations.

Who We Support

MGS can provide contamination-control support for:

  • Sterile manufacturing facilities
  • Non-sterile pharmaceutical facilities
  • API manufacturers
  • Biopharmaceutical organizations
  • Medical-device manufacturers
  • High-potency facilities
  • Containment facilities
  • Laboratories
  • New facility projects
  • Existing facilities undergoing remediation or expansion

SERVICE SUPPORT

Control Contamination Before It Becomes a Quality Risk

A strong Contamination Control Strategy connects facility design, process controls, cleaning, monitoring, people, and quality systems into one coordinated framework.
Partner with MGS for practical, risk-based, and integrated contamination-control support.